The ACSS Consortium welcomes the UK as its newest member
Published
Related content
- Access Consortium regulators pledge support to tackle COVID-19The Access Consortium regulatory authorities have pledged their collective support in countering the COVID-19 global pandemic
- TGA supports MHRA’s new international recognition framework for medicinesThese international recognition routes, which have been facilitated by existing international partnerships such as those developed through the Access Consortium and Project Orbis, are part of a new international recognition framework for medicines that is specific to the UK following their exit from the European Union.
- International work-sharing - First medicines approved by all five Access Consortium regulatorsTGA approves asciminib and faricimab through the Access New Active Substance Work-Sharing Initiative